3192 results for «988»
3192 results
Heart Team in action: managing complex cases together
17 Feb 2024 – From PCR Tokyo Valves 2024
In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments.
Managing aortic stenosis in patients with longer life expectancy
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to understand what knowledge is needed for discussions with patients concerning lifetime management of valve disease, gain insight into the importance of predictable and precise commissural and coronary alignment for lifetime management, and learn about the indication of TAV-in-TAV and THV explant.
Tricuspid valve interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session if you want to understand T-TEER/TTVR procedure, learn about clinical indication and appropriate patient selection for TEER/TTVR based on TRILUMINATE trial/TRISCEND study, and update your knowledge of current transcatheter technologies for tricuspid regurgitation.
Challenging situations in mitral valve interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
This selection of cases showcases a number of challenging situations in mitral valve interventions and how best to resolve them. Among such complications are a severe afterload mismatch following M-TEER in functional mitral regurgitation, a detached clip in the left atrium, and more.
Rapid-fire - Outcome studies after valvular intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
This session of rapid-fire submitted cases focuses on outcome studies after valvular intervention. Learn about clinical impacts of cerebral micro-bleeds in patients undergoing TAVI, explore the long-term outcomes of Venus P valve for dysfunctional right ventricular outflow tract, and more!
Calcified left main distal trifurcation PCI - LIVE Case
30 Jan 2026 – From SASCI-AfricaPCR
A 48‑year‑old man with hypertension and diabetes mellitus presented with a recent history of thrombolysed anterior acute MI and preserved left ventricular function. Coronary angiography revealed a severely calcified ostial LAD and ostial ramus lesion, along with diffuse disease of the RCA.
The ramus was treated with...
Left main and LAD bifurcation - LIVE Case
30 Jan 2026 – From SASCI-AfricaPCR
A 59‑year‑old man with a history of STEMI in 2019 (Cx PCI), as well as hypertension and dyslipidemia, presented with CCS class III angina. Coronary angiography revealed a chronic total occlusion (CTO) of the OM2 and a calcified ostial lesion of the LAD and first diagonal...
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
Outcomes in patients with atrial fibrillation randomized to receive LAA closure or oral anticoagulation: Primary results of the CHAMPION-AF clinical trial
28 Mar 2026
During the first Late-Breaking Trial session of the 2026 ACC Congress held in New Orleans, Saibal Kar, principal investigator of the CHAMPION-AF trial, presented the 3-year results of this groundbreaking study, which were simultaneously published in the NEJM (DOI: 10.1056/NEJMoa2517213).
Author
TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation
04 Mar 2023
Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Author
The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial
25 Oct 2023
Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...
Author
TRI.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation
31 Aug 2024
Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.
Author
